Insider Selling: Renalytix (LON:RENX) Insider Sells £70,000.02 in Stock

Renalytix Plc (LON:RENX) insider Christopher Mills sold 1,166,667 shares of the stock in a transaction on Tuesday, September 29th. The shares were sold at an average price of GBX 6, for a total value of £70,000.02.

Renalytix Trading Down 3.3%

RENX opened at GBX 5.80 on Friday. The firm has a market cap of £25.35 million, a price-to-earnings ratio of -1.45 and a beta of 1.81. Renalytix Plc has a 12 month low of GBX 1.60 and a 12 month high of GBX 10. The stock has a fifty day moving average price of GBX 4.60 and a 200-day moving average price of GBX 2.97. The company has a current ratio of 1.57, a quick ratio of 2.42 and a debt-to-equity ratio of -483.33.

Renalytix Company Profile

Renalytix (LSE: RENX) (NASDAQ: RNLX) is a developer of artificial intelligence-enabled clinical in vitro diagnostic solutions for kidney disease, one of the most common and costly chronic medical conditions globally. The Company’s lead product is KidneyIntelX, which has been granted Breakthrough Designation by the U.S. Food and Drug Administration and which is being designed to help make significant improvements in kidney disease prognosis, transplant management, clinical care, patient stratification for drug clinical trials, and drug target discovery (visit www.kidneyintelx.com).